Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
| TEAD3 + high-risk melanoma cells crosstalk with GAS6 + macrophages via the GAS6-TYRO3 ligand-receptor axis to modulate propionate metabolism and drive melanoma progression. | J Exp Clin Cancer Res | 2025 | 41034991 | PubTator, text mining | PubMed |
| Targeting FAK to Potentiate Immune Checkpoint Therapy in Solid Tumors. | J Cancer Immunol (Wilmington) | 2025 | 41019359 | PubTator, text mining | PubMed |
| Molecular basis of vitamin K-dependent protein γ-glutamyl carboxylation. | Cell Res | 2025 | 41016932 | PubTator, text mining | PubMed |
| The Receptor Tyrosine Kinase Axl in (Advanced) Gastric Cancer-From Pathophysiology to Therapeutic Impact. | Medicina (Kaunas) | 2025 | 41011010 | PubTator, text mining | PubMed |
| Variation in virion phosphatidylserine content drives differential GAS6 binding among closely related flaviviruses. | J Virol | 2025 | 40990511 | PubTator, text mining | PubMed |
NADH supplementation improves human oocyte maturation and developmental competence of resulting embryos in controlled ovarian hyperstimulation cycles: a pilot study implicating the CDK2/GAS6 signaling pathway. | Front Endocrinol (Lausanne) | 2025 | 40969372 | PubTator, text mining | PubMed |
| Personalised immunotherapy strategies informed by single cell profiling in thyroid cancer: a mini review. | Front Immunol | 2025 | 40959084 | PubTator, text mining | PubMed |
| Growth Arrest-Specific Protein 6 Is Elevated in Endometriosis but Shows Poor Diagnostic Performance. | Int J Mol Sci | 2025 | 40943271 | PubTator, text mining | PubMed |
| Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. | Cancers (Basel) | 2025 | 40940956 | PubTator, text mining | PubMed |
| Detection of Gas6/AXL complex and its expression changes in patients with ST-segment elevation myocardial infarction. | Front Med (Lausanne) | 2025 | 40933570 | PubTator, text mining | PubMed |
| Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy. | Korean J Clin Oncol | 2025 | 40916400 | PubTator, text mining | PubMed |
| [Bioinformatics analysis of efferocytosis-related genes in diabetic kidney disease and screening of targeted traditional Chinese medicine]. | Zhongguo Zhong Yao Za Zhi | 2025 | 40904090 | PubTator, text mining | PubMed |
| DECIPHER for learning disentangled cellular embeddings in large-scale heterogeneous spatial omics data. | Nat Commun | 2025 | 40866331 | PubTator, text mining | PubMed |
| Reversing Preeclampsia Pathology: AXL Inhibition Restores Mitochondrial Function and ECM Balance. | Cells | 2025 | 40862707 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields macrophage-secreted drivers of invasion. | JCI Insight | 2025 | 40857405 | PubTator, text mining | PubMed |
| An iPSC-based in vitro model recapitulates human thymic epithelial development and multi-lineage specification. | Nat Commun | 2025 | 40855082 | PubTator, text mining | PubMed |
| SFTSV utilizes AXL/GAS6 for entry via PI3K-PLC-dependent macropinocytosis activated by AXL-kinase. | J Virol | 2025 | 40853130 | PubTator, text mining | PubMed |
| Clinical applications of circulating tumor cells in metastasis and therapy. | J Hematol Oncol | 2025 | 40846962 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma. | NPJ Precis Oncol | 2025 | 40835726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=7